Client News

Spexis announces business update call to be held on July 28th

CEVEC’s license partner RZNOMICS Inc. receives approval to initiate clinical development of CAP® Ad Technology-produced gene therapy vector in liver cancer patients

Adrenomed appoints David Germonpré as Chief Financial Officer

VisionHealth and Boehringer Ingelheim: Digital therapy support for asthma and COPD

Destiny Pharma receives award from the Cystic Fibrosis Foundation

Heidelberg Pharma Reports on First Half-Year 2022

Andera Partners strengthens its Life Sciences team with a new partner

Destiny Pharma announces publication of XF-73 drug synergy data

Carbios, On, Patagonia, PUMA and Salomon team up to advance circularity in the textile industry

InflaRx Receives FDA Fast Track Designation for Treatment of Ulcerative Pyoderma Gangrenosum